BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He MH, Chen L, Zheng T, Tu Y, He Q, Fu HL, Lin JC, Zhang W, Shu G, He L, Yuan ZX. Potential Applications of Nanotechnology in Urological Cancer. Front Pharmacol 2018;9:745. [PMID: 30038573 DOI: 10.3389/fphar.2018.00745] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Song FX, Xu X, Ding H, Yu L, Huang H, Hao J, Wu C, Liang R, Zhang S. Recent Progress in Nanomaterial-Based Biosensors and Theranostic Nanomedicine for Bladder Cancer. Biosensors (Basel) 2023;13. [PMID: 36671940 DOI: 10.3390/bios13010106] [Reference Citation Analysis]
2 Li G, Wu S, Chen W, Duan X, Sun X, Li S, Mai Z, Wu W, Zeng G, Liu H, Chen T. Designing Intelligent Nanomaterials to Achieve Highly Sensitive Diagnoses and Multimodality Therapy of Bladder Cancer. Small Methods 2023;:e2201313. [PMID: 36599700 DOI: 10.1002/smtd.202201313] [Reference Citation Analysis]
3 Belkahla S, Nahvi I, Biswas S, Nahvi I, Ben Amor N. Advances and development of prostate cancer, treatment, and strategies: A systemic review. Front Cell Dev Biol 2022;10:991330. [DOI: 10.3389/fcell.2022.991330] [Reference Citation Analysis]
4 Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules 2022;27:5730. [PMID: 36080493 DOI: 10.3390/molecules27175730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Halib N, Pavan N, Trombetta C, Dapas B, Farra R, Scaggiante B, Grassi M, Grassi G. An Overview of siRNA Delivery Strategies for Urological Cancers. Pharmaceutics 2022;14:718. [DOI: 10.3390/pharmaceutics14040718] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Salvadori MR. Nanomedicine and Its Potential Therapeutic and Diagnostic Applications in Human Pathologies. Nanotechnology in the Life Sciences 2022. [DOI: 10.1007/978-3-030-82918-6_13] [Reference Citation Analysis]
7 Shah MR, Imran M, Ullah S. Targeted nano drug delivery systems for renal disorders. Nanocarriers for Organ-Specific and Localized Drug Delivery 2022. [DOI: 10.1016/b978-0-12-821093-2.00002-5] [Reference Citation Analysis]
8 Loloi J, Babar M, Davies KP, Suadicani SO. Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases. Therapeutic Advances in Urology 2022;14:175628722211090. [DOI: 10.1177/17562872221109023] [Reference Citation Analysis]
9 Shen W, Ge S, Liu X, Yu Q, Jiang X, Wu Q, Tian Y, Gao Y, Liu Y, Wu C. Folate-functionalized SMMC-7721 liver cancer cell membrane-cloaked paclitaxel nanocrystals for targeted chemotherapy of hepatoma. Drug Deliv 2022;29:31-42. [PMID: 34962215 DOI: 10.1080/10717544.2021.2015481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Xu Y, Luo C, Wang J, Chen L, Chen J, Chen T, Zeng Q. Application of nanotechnology in the diagnosis and treatment of bladder cancer. J Nanobiotechnology 2021;19:393. [PMID: 34838048 DOI: 10.1186/s12951-021-01104-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
11 Mittal A, Kumar Panwar V, Singh G. Advancements in Intravesical Chemotherapy in Non-Muscle Invasive Bladder Cancer. Modern Approach to Diagnosis and Treatment of Bladder Cancer 2021. [DOI: 10.5772/intechopen.99441] [Reference Citation Analysis]
12 Anadozie SO, Adewale OB, Meyer M, Davids H, Roux S. In vitroanti-oxidant and cytotoxic activities of gold nanoparticles synthesized from an aqueous extract of theXylopia aethiopicafruit. Nanotechnology 2021;32. [PMID: 33845465 DOI: 10.1088/1361-6528/abf6ee] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Barani M, Hosseinikhah SM, Rahdar A, Farhoudi L, Arshad R, Cucchiarini M, Pandey S. Nanotechnology in Bladder Cancer: Diagnosis and Treatment. Cancers (Basel) 2021;13:2214. [PMID: 34063088 DOI: 10.3390/cancers13092214] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 16.5] [Reference Citation Analysis]
14 Takke A, Shende P. Magnetic-core-based silibinin nanopolymeric carriers for the treatment of renal cell cancer. Life Sci 2021;275:119377. [PMID: 33757771 DOI: 10.1016/j.lfs.2021.119377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Barani M, Sabir F, Rahdar A, Arshad R, Kyzas GZ. Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates. Nanomaterials (Basel) 2020;10:E1696. [PMID: 32872181 DOI: 10.3390/nano10091696] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 13.7] [Reference Citation Analysis]
16 Othman HO, Salehnia F, Fakhri N, Hassan R, Hosseini M, Faizullah A, Ganjali MR, Kazem Aghamir SM. A highly sensitive fluorescent immunosensor for sensitive detection of nuclear matrix protein 22 as biomarker for early stage diagnosis of bladder cancer. RSC Adv 2020;10:28865-71. [PMID: 35520044 DOI: 10.1039/d0ra06191c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Gao X, Wang B, Liu Q, Liu C, Li M, Sirkar KK, Chen D. Fluid Dynamic and Heat Transfer Simulations of Solid Hollow Fiber Cooling Crystallizer for Continuous Synthesis of Drug Nanoparticles. Crystal Growth & Design 2020;20:4020-4029. [DOI: 10.1021/acs.cgd.0c00307] [Reference Citation Analysis]
18 Caparica R, Júlio A, Araújo MEM, Baby AR, Fonte P, Costa JG, Santos de Almeida T. Anticancer Activity of Rutin and Its Combination with Ionic Liquids on Renal Cells. Biomolecules 2020;10:E233. [PMID: 32033222 DOI: 10.3390/biom10020233] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 18.7] [Reference Citation Analysis]
19 Ju HY, Hu KX, Zhao GW, Tang ZS, Song X. Design, Preparation, and Characterization of Dioscin Nanosuspensions and Evaluation of Their Protective Effect against Carbon Tetrachloride-Induced Acute Liver Injury in Mice. Evid Based Complement Alternat Med 2019;2019:3907915. [PMID: 31814841 DOI: 10.1155/2019/3907915] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
20 Elistratova J, Mukhametshina A, Kholin K, Nizameev I, Mikhailov M, Sokolov M, Khairullin R, Miftakhova R, Shammas G, Kadirov M, Petrov K, Rizvanov A, Mustafina A. Interfacial uploading of luminescent hexamolybdenum cluster units onto amino-decorated silica nanoparticles as new design of nanomaterial for cellular imaging and photodynamic therapy. Journal of Colloid and Interface Science 2019;538:387-96. [DOI: 10.1016/j.jcis.2018.12.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]